Daniel A. Rubé, Ph.D.

Dr. Rubé’s practice involves prosecution of patent applications in the biological, pharmaceutical and chemical arts. He also prepares opinions on non-infringement and freedom-to-operate.

His research experience focused on cell biology and biochemistry, with an emphasis on mitochondria and vesicle trafficking. Dr. Rubé has experience prosecuting patents in a variety of fields, including stem cell isolation, cancer detection and treatment, pharmaceutical formulations and medical devices. He has significant experience with managing the prosecution of patent families in a variety of foreign jurisdictions. Additionally, he has experience in preparing drafts of ex parte reexamination requests.

• NIH Genetics Training Grant Award, UCLA, 1997-2001
• Academic Excellence in Chemistry Award, UB Department of Chemistry, 1996
• Phi Beta Kappa, State University of New York at Buffalo

• "Are Covenants to Sue in Patent Litigation Rejectable Under Bankruptcy Code Section 365?" BNA Bankruptcy Law Reporter, June 17, 2011
• "Mitochondrial morphology is dynamic and varied," co-author, Molecular and Cellular Biochemistry, 256-257(1-2):331-339, 2004
• "Endophilin is required for synaptic vesicle endocytosis by localizing synaptojanin," co-author, Neuron, 40(4):749-762, 2003
• "C. elegans dynamin-related protein DRP-1 controls severing of the mitochondrial outer membrane," co-author, Molecular Cell, 4, 815-826, 1999